SynthesisBMC nephrology2026

Efficacy and safety analysis of different treatment schemes of erythropoiesis-stimulating agents for chronic kidney disease with anemia: a meta analysis between 2000-2024.

Ruilin Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.